Ivabradine in Management of Heart Failure: a Critical Appraisal.

about

Ivabradine in Management of Heart Failure: a Critical Appraisal.

Item

http://www.wikidata.org/entity/Q38546740

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ivabradine in Management of Heart Failure: a Critical Appraisal.

@en

type

Item

label

Ivabradine in Management of Heart Failure: a Critical Appraisal.

@en

prefLabel

Ivabradine in Management of Heart Failure: a Critical Appraisal.

@en

P1476

Ivabradine in Management of Heart Failure: a Critical Appraisal.

@en

P2093

Gabriela Orasanu

http://www.w3.org/2001/XMLSchema#string

Guilherme H Oliveira

http://www.w3.org/2001/XMLSchema#string

Sadeer G Al-Kindi

http://www.w3.org/2001/XMLSchema#string

P2860

Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.

Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.

Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.

Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice

Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis

P2888

s11897-016-0276-x

P304

60-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-016-0276-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040711979

http://www.w3.org/2001/XMLSchema#string

P698

26797824

http://www.w3.org/2001/XMLSchema#string